| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
poly(ADP-ribose) polymerase 2 | 0.663 | 0.538 | 2.3E-13 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
microRNA 4262 | 0.722 | 0.231 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
long intergenic non-protein coding RNA 673 | 0.659 | 0.462 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
microRNA 374c | 0.805 | 0.231 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
microRNA 3941 | 0.839 | 0.154 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
microRNA 3666 | 0.700 | 0.308 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
long intergenic non-protein coding RNA 1133 | 0.638 | 0.500 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
GAS5 antisense RNA 1 | 0.769 | 0.269 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
DSCAM antisense RNA 1 | 0.722 | 0.346 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | |||||||||
|
occludin | 0.507 | 0.846 | 8.6E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
prostate cancer associated transcript 6 | 0.666 | 0.269 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
caspase 12 (gene/pseudogene) | 0.638 | 0.808 | 1.3E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
GIHCG inhibitor of miR-200b/200a/429 expression | 0.736 | 0.231 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
DLG1 antisense RNA 1 | 0.839 | 0.115 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
ATP binding cassette subfamily F member 2 | 0.780 | 0.154 | 1.1E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
microRNA 4636 | 0.890 | 0.077 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | |||||||||
|
microRNA 4784 | 0.861 | 0.115 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
microRNA 4778 | 0.890 | 0.077 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
microRNA 4429 | 0.751 | 0.192 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | |||||||||
|
SPRY4 intronic transcript 1 | 0.619 | 0.462 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
NNT antisense RNA 1 | 0.666 | 0.423 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
focally amplified long non-coding RNA in epithelial cancer | 0.644 | 0.423 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
papillary thyroid carcinoma susceptibility candidate 3 | 0.722 | 0.385 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | |||||||||
|
promoter of CDKN1A antisense DNA damage activated RNA | 0.623 | 0.577 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 |